MX2017000083A - Compuestos de platino, composiciones y usos de estos. - Google Patents

Compuestos de platino, composiciones y usos de estos.

Info

Publication number
MX2017000083A
MX2017000083A MX2017000083A MX2017000083A MX2017000083A MX 2017000083 A MX2017000083 A MX 2017000083A MX 2017000083 A MX2017000083 A MX 2017000083A MX 2017000083 A MX2017000083 A MX 2017000083A MX 2017000083 A MX2017000083 A MX 2017000083A
Authority
MX
Mexico
Prior art keywords
compositions
platinum compounds
reacting
protein
antibody
Prior art date
Application number
MX2017000083A
Other languages
English (en)
Inventor
Mark T Bilodeau
Moreau Benoit
Meetze Kristan
Singh Sukhjeet
Wooster Richard
Whalen Kerry
Andre LEMELIN Charles-
Original Assignee
Placon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54938720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017000083(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Placon Therapeutics Inc filed Critical Placon Therapeutics Inc
Publication of MX2017000083A publication Critical patent/MX2017000083A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System

Abstract

Las presentes instrucciones se relacionan con compuestos y composiciones para el tratamiento de cánceres. En algunas modalidades, la composición comprende un complejo de platino (IV) que tiene al menos un grupo reactivo adecuado para la reacción con un grupo funcional en una proteína, proteína diseñada genéticamente, anticuerpo, fragmento de anticuerpo, péptido, agonista, antagonista, aptámero o ligando que puede ser capaz de reconocer una población de células objetivo seleccionada y/o derivados/análogos/miméticos de estos.
MX2017000083A 2014-06-23 2015-06-23 Compuestos de platino, composiciones y usos de estos. MX2017000083A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201462015714P 2014-06-23 2014-06-23
US201462034124P 2014-08-06 2014-08-06
US201462035126P 2014-08-08 2014-08-08
US201462035739P 2014-08-11 2014-08-11
US201562150045P 2015-04-20 2015-04-20
PCT/US2015/037071 WO2015200250A1 (en) 2014-06-23 2015-06-23 Platinum compounds, compositions, and uses thereof

Publications (1)

Publication Number Publication Date
MX2017000083A true MX2017000083A (es) 2017-05-30

Family

ID=54938720

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000083A MX2017000083A (es) 2014-06-23 2015-06-23 Compuestos de platino, composiciones y usos de estos.

Country Status (14)

Country Link
US (3) US9403858B2 (es)
EP (2) EP3157515B1 (es)
JP (2) JP6336681B2 (es)
KR (1) KR101915452B1 (es)
CN (1) CN106659706B (es)
AU (2) AU2015280204B2 (es)
BR (1) BR112016030310A2 (es)
CA (1) CA2953350C (es)
IL (1) IL249646B (es)
MX (1) MX2017000083A (es)
NZ (1) NZ727701A (es)
SG (1) SG11201610656QA (es)
WO (1) WO2015200250A1 (es)
ZA (1) ZA201608543B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10011622B2 (en) * 2013-12-31 2018-07-03 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
AU2015280204B2 (en) * 2014-06-23 2018-10-18 Xlink Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
US20180186823A1 (en) * 2015-06-23 2018-07-05 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
EP3313392B1 (en) * 2015-06-23 2020-09-16 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
PT3386997T (pt) * 2015-12-09 2021-11-04 Univ Wien Med Compostos de platina com funções de mono-maleimida para a terapêutica do cancro
CN105622674B (zh) * 2016-02-29 2018-02-02 东南大学 一类含有生物活性基团的四价铂配合物及其制备方法
CN106046062B (zh) * 2016-07-01 2018-09-11 中国科学院上海药物研究所 两亲性奥沙利铂前体，其制备方法及用途
CN110950915B (zh) * 2019-12-24 2022-07-22 玉林师范学院 一种新型大黄酸类-铂(iv)前体抗癌配合物及其合成方法与应用
CN111205331B (zh) * 2020-02-24 2021-06-15 南京大学 一种具有抗耐药性功能的抗肿瘤四价铂配合物及制备方法
CN114539320A (zh) * 2020-11-25 2022-05-27 北京大学 辐射激活的四价铂配合物及其用途
CN114249773B (zh) * 2021-12-06 2022-12-30 苏州大学 释放一氧化氮的四价铂类化合物及其制备和应用
CN114230616B (zh) * 2022-02-22 2022-04-29 江苏南创化学与生命健康研究院有限公司 一种癌细胞靶向的抗癌Pt配合物及其制备方法与应用
CN116621900B (zh) * 2023-01-10 2024-05-07 河南大学 一种基于调控Mucin型O-糖基化靶向CRPC的四价铂氨基己糖配合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550187A (en) 1984-04-12 1985-10-29 The Research Foundation Of State University Of New York Synthesis of platinum (IV) antineoplastic agents
US5041578A (en) 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5622929A (en) 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
BR9508554A (pt) 1994-08-08 1997-11-25 Debiopharm Sa Preparação farmaceuticamente estável de oxaliplatina
DK1368022T3 (da) 2001-03-02 2007-10-01 Debiopharm Sa Anvendelse af en flaske indeholdende en oxaliplatinoplösning
WO2004037311A2 (en) 2002-10-21 2004-05-06 Kensey Nash Corporation Device and methods for sequential, regional delivery of multiple cytotoxic agents
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations
EP2169067A1 (en) 2004-12-22 2010-03-31 Novozymes A/S Recombinant production of serum albumin
GB0522569D0 (en) 2005-11-04 2005-12-14 Univ Bath Biocompatible drug delivery device
US10172953B2 (en) 2012-02-27 2019-01-08 Amunix Operating Inc. XTEN conjugate compositions and methods of making same
US20130252832A1 (en) 2012-03-22 2013-09-26 Yale University KRAS Variant and Tumor Biology
US10058688B2 (en) 2012-05-09 2018-08-28 Massachusetts Institute Of Technology Medicament, method, and drug delivery device for treatment of ovarian cancer
DK2890384T3 (da) 2012-08-31 2022-01-10 Taris Biomedical Llc Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin
US9301926B2 (en) 2013-04-10 2016-04-05 Massachusetts Institute Of Technology Local drug delivery devices and methods for treating cancer
WO2015017506A2 (en) 2013-07-30 2015-02-05 Blend Therapeutics, Inc. Nanoparticle diagnostic and methods for treating disease
WO2015023557A1 (en) 2013-08-12 2015-02-19 Nanomedical Systems, Inc. Device and method for sustained release of low water solubility therapeutic agent in solubilizer
US10011622B2 (en) * 2013-12-31 2018-07-03 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
AU2015280204B2 (en) * 2014-06-23 2018-10-18 Xlink Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
US20180186823A1 (en) * 2015-06-23 2018-07-05 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
PT3386997T (pt) * 2015-12-09 2021-11-04 Univ Wien Med Compostos de platina com funções de mono-maleimida para a terapêutica do cancro

Also Published As

Publication number Publication date
KR20170021854A (ko) 2017-02-28
CA2953350C (en) 2019-11-26
IL249646A0 (en) 2017-02-28
CN106659706A (zh) 2017-05-10
KR101915452B1 (ko) 2018-11-06
US20180008614A1 (en) 2018-01-11
NZ727701A (en) 2018-04-27
JP2018141000A (ja) 2018-09-13
JP6659764B2 (ja) 2020-03-04
US10322137B2 (en) 2019-06-18
BR112016030310A2 (pt) 2017-08-22
US20160317549A1 (en) 2016-11-03
JP6336681B2 (ja) 2018-06-06
JP2017522377A (ja) 2017-08-10
AU2015280204A1 (en) 2017-01-12
CA2953350A1 (en) 2015-12-30
EP3157515A1 (en) 2017-04-26
AU2015280204B2 (en) 2018-10-18
EP3157515B1 (en) 2021-05-26
AU2018236864A1 (en) 2018-10-18
ZA201608543B (en) 2019-04-24
US9403858B2 (en) 2016-08-02
SG11201610656QA (en) 2017-01-27
US9937187B2 (en) 2018-04-10
EP3797768A1 (en) 2021-03-31
IL249646B (en) 2019-05-30
CN106659706B (zh) 2020-03-20
EP3157515A4 (en) 2018-01-03
US20160068557A1 (en) 2016-03-10
WO2015200250A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
MX2017000083A (es) Compuestos de platino, composiciones y usos de estos.
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
BR112018068703A2 (pt) inibidores substituídos de menin-mll e métodos de uso
BR112017020054A2 (pt) anticorpos para icos
EA201792583A1 (ru) Способы и композиции для ингибирования взаимодействия менина с белками mll
PH12015502039B1 (en) Anti-lag-3 binding proteins
MX2022010324A (es) Sitios especificos para modificar anticuerpos para hacer inmunoconjugados.
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201591515A1 (ru) Полипептиды il-22, химерные белки il-22 fc и их применение
EA201592269A1 (ru) Способы и композиции для снижения иммуносупрессии опухолевыми клетками
MA38500A1 (fr) Systèmes et procédés pour analyser une nourriture pour animal
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
TW201613974A (en) Tumor-selective CTLA-4 antagonists
MY176200A (en) Binding polypeptides having a mutated scaffold
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
MX2021001418A (es) Produccion de proteinas heteromultimericas usando celulas de mamifero.
EA201590061A1 (ru) Фармацевтическая композиция
BR112016021066A2 (pt) anticorpos humanizados com estabilidade aumentada
EA201791716A1 (ru) Фармацевтический состав
MX2019002818A (es) Metodos para detectar anticuerpos neutralizantes anti-leptina.
EA201891482A1 (ru) Модифицированные антитела для сайт-специфической конъюгации
MX2015015015A (es) Metodo para diagnosticar cancer.
MX2017005310A (es) Metodos basados en proximidad para seleccion de parejas para ligadura.